Revenue growth was actually a beat but there was significant earnings pressure from underperforming unit. Seems like a temporary speed bump to me. Now yielding 3.4% which is pretty high for them. Possibly even more interesting is that McKesson ($MCK) is down 6% as a reaction but obviously doesn’t have that same underperforming business unit. The other of the big 3 drug makers ($ABC) posted a beat on Q1 earnings. McKesson reports later this month.
Anybody watching this one?
https://www.google.com/amp/s/mobile.reuters.com/article/amp/idUSKBN1I417O
Submitted May 03, 2018 at 10:34AM by Lerk409 https://ift.tt/2HMOaUz
